Lv1
20 积分 2022-10-12 加入
Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platform
21天前
已完结
Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons
22天前
已完结
Advances in Targeting HER2 across Cancer Subtypes – A Pan-tumor Approach
1个月前
已完结
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives
1个月前
已完结
FDA approvals for pediatric cancer indications using children’s oncology group associated trials data
1个月前
已完结
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
1个月前
已完结
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
2个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
2个月前
已完结
Testicular Germ Cell Tumors
2个月前
已完结
Long-term trends and disparities in primary intracranial germ cell tumor incidence and mortality for child and adolescent in the USA
2个月前
已完结
皖公网安备34019202002308
